Weifang Ruze New Material Co., Ltd.

 

Your Aspiration is Our Commitment

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAntineoplastic Drugs

Trelagliptin Succinate CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

Ruze supply good service, thanks.

—— Gaurav

I'm Online Chat Now

Trelagliptin Succinate CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

China Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor supplier
Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor supplier Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor supplier

Large Image :  Trelagliptin Succinate CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

Product Details:

Place of Origin: Weifang,China
Brand Name: RuzE
Model Number: TC-5008

Payment & Shipping Terms:

Minimum Order Quantity: Negotiable
Price: Negotiable
Packaging Details: 25kg Alumium Foil Bag
Delivery Time: 5-10work days
Payment Terms: L/C, T/T, Western Union, MoneyGram
Supply Ability: 100kg/Month
Contact Now
Detailed Product Description
Product Name: Trelagliptin Succinate Synonyms: Trelagliptin Succinate - SYR 111472 Succinate | SYR 472;SRY-472;Telagliptin Succinate;Trelagliptin Succinate, >=98%;2-[[6-[(3R)-3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile,butanedioicacid;Trelagliptin Succinate API;
CAS: 1029877-94-8 MF: C22H26FN5O6
MW: 475.4701432

Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

             

                                                              Trelagliptin succinate

 

[PRODUCT NAME]:Trelagliptin succinate

[CATALOG NUMBER]:

[CAS NUMBER]:1029877-94-8

[MOLECULAR FORMULA]:C22H26FN5O6

[MOLECULAR WEIGHT]:475.47000

[BATCH NO]:20190226

[TEST]:SPECIFICATION

[APPEARANCE]: White Crystal Powder

[ASSAY]: 99%min

[WATER]: 0.5%max


Trelagliptin succinate Chemical Properties

storage temp. -20°C
color Off-white solid

 

Trelagliptin succinate Usage And Synthesis 

Uses Trelagliptin succinate (SYR-472) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor. An antidiabetic agent.
Orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. SYR472 has a long duration of action and is well tolerated in clinical studies.
Clinical Use Trelagliptin (SYR-472), a novel dipeptidyl peptidase-4 inhibitor used for the treatment of type 2 diabetes mellitus. Trelagliptin (as the salt Trelagliptin succinate) was approved for use in Japan in March 2015. Takeda, the company that developed Trelagliptin, chose to not get approval for the drug in the USA and EU.
Research Trelagliptin (Zafatek) is an orally active DPP-4 inhibitor developed by Takeda and approved in Japan for the treatment of type 2 diabetes mellitus (T2DM). Unlike other approved agents of its class, which are usually administered once daily, trelagliptin can be administered once weekly. Phase II development of trelagliptin was discontinued in the USA and EU, as Takeda considered that the costs associated with obtaining approval in these markets were prohibitive.

Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitorTrelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitorTrelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitorTrelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

 

Trelagliptin Succinate  CAS: 1029877 94 8 Assay 99% a novel dipeptidyl peptidase-4 inhibitor

Contact Details
Weifang Ruze New Material Co., Ltd.

Contact Person: Ruze01

Send your inquiry directly to us (0 / 3000)